4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

81.00p
   
  • Change Today:
    -2.75p
  • 52 Week High: 190.00
  • 52 Week Low: 68.83
  • Currency: UK Pounds
  • Shares Issued: 65.49m
  • Volume: 68,200
  • Market Cap: £53.05m
  • Beta: 0.07

Latest ShareCast News

Director dealings: 4D Pharma board up stakes

By Iain Gilbert

Date: Wednesday 22 May 2019

(Sharecast News) - 4D Pharma revealed that chief executive Duncan Peyton had acquired 101,199 ordinary shares in the AIM-listed drugmaker on Wednesday.

4D Pharma losses widen as it spends cash on development activities

By Josh White

Date: Tuesday 21 May 2019

(Sharecast News) - Biotherapeutics development company 4D Pharma reported net assets of £45.8m in its final results on Tuesday, falling from £69.8m year-on-year.

4d Pharma buoyed by Texas cancer treatment partnership

By Duncan Ferris

Date: Monday 07 Jan 2019

(Sharecast News) - 4d Pharma's shares enjoyed a boost on Monday after entering a collaboration with a specialist cancer unit at the University of Texas.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4D Pharma Market Data

Currency UK Pounds
Share Price 81.00p
Change Today -2.75p
% Change -3.28 %
52 Week High 190.00
52 Week Low 68.83
Volume 68,200
Shares Issued 65.49m
Market Cap £53.05m
Beta 0.07

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
1.35% below the market average1.35% below the market average1.35% below the market average1.35% below the market average1.35% below the market average
10% below the sector average10% below the sector average10% below the sector average10% below the sector average10% below the sector average
Price Trend
87.86% below the market average87.86% below the market average87.86% below the market average87.86% below the market average87.86% below the market average
77.05% below the sector average77.05% below the sector average77.05% below the sector average77.05% below the sector average77.05% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

4D Pharma Dividends

No dividends found

Trades for 16-Aug-2019

Time Volume / Share Price
17:04 3,000 @ 81.00p
16:29 3,000 @ 82.44p
16:24 1,895 @ 79.50p
13:56 3,000 @ 79.00p
13:56 2,000 @ 79.00p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page